RxDoctor Payments Data

Sam Meshkinfam, DO

Facial Plastic Surgery · Florence, SCNPI 1952657348

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,159 of the $2,920 with a category attached, or 74.0%. Stryker accounts for 78.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $1,335 and has fallen 88.0% since, to $160 in 2024.

$2,920in general payments, 2019–2025

Across 51 payments — averaging $57.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Sanofi$166
  • Optinose US, Inc.$115
  • Cochlear Americas$104
  • Inspire Medical Systems, Inc.$81
  • GSK$68
  • plus $106 from 4 others

What the payments were for

  • Travel & lodging$76126%
  • Food & beverage$2,15974%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few facial plastic surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$16,665
Medicare patients
97
Services billed
161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl23$622
Fluticasone Propionate21$407

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →